Lengthening Adalimumab Dosing Interval in Quiescent Crohn's Disease Patients
Clinical trial NCT03172377 · UNKNOWN
Trial details
- NCT number
- NCT03172377
- Sponsor
- Radboud University Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-03
- Primary completion
- 2022-10-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.